Wedbush Securities Inc Regeneron Pharmaceuticals, Inc. Transaction History

Wedbush Securities Inc

$2.68 Billion
Q1 2024

A detailed history of Wedbush Securities Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wedbush Securities Inc holds 696 shares of REGN stock, worth $712,766. This represents 0.02% of its overall portfolio holdings.

Number of Shares

696

Previous 594 17.17%

Holding current value

$712,766

Previous $522,000 28.35%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $92,074 - $101,321	102 Added 17.17%	696 $670,000
Q4 2023 Feb 12, 2024	SELL	$775.18 - $881.7 $5,426 - $6,171	-7 Reduced 1.16%	594 $522,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $38,084 - $46,440	-55 Reduced 8.38%	601 $495,000
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $26,601 - $31,553	38 Added 6.15%	656 $471,000
Q1 2023 May 09, 2023	BUY	$680.49 - $826.97 $45,592 - $55,406	67 Added 12.16%	618 $508,000

Q4 2022 Jan 31, 2023	SELL	$705.89 - $766.39 $51,529 - $55,946	-73 Reduced 11.7%	551 $398,000
Q3 2022 Oct 18, 2022	SELL	$573.97 - $724.32 $67,154 - $84,745	-117 Reduced 15.79%	624 $429,000
Q2 2022 Jul 21, 2022	SELL	$548.35 - $738.84 $50,996 - $68,712	-93 Reduced 11.15%	741 $438,000
Q1 2022 Apr 19, 2022	SELL	$595.12 - $698.43 $21,424 - $25,143	-36 Reduced 4.14%	834 $582,000
Q4 2021 Jan 13, 2022	BUY	$543.48 - $670.97 $129,348 - $159,690	238 Added 37.66%	870 $549,000
Q3 2021 Oct 08, 2021	SELL	$574.03 - $680.96 $5,166 - $6,128	-9 Reduced 1.4%	632 $382,000
Q2 2021 Jul 27, 2021	SELL	$472.8 - $558.54 $75,648 - $89,366	-160 Reduced 19.98%	641 $358,000
Q1 2021 Apr 26, 2021	SELL	$446.73 - $548.2 $241,680 - $296,576	-541 Reduced 40.31%	801 $378,000
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $119,575 - $151,995	250 Added 22.89%	1,342 $648,000
Q3 2020 Oct 20, 2020	BUY	$544.75 - $658.21 $13,074 - $15,797	24 Added 2.25%	1,092 $611,000
Q2 2020 Jul 16, 2020	BUY	$493.32 - $643.92 $277,739 - $362,526	563 Added 111.49%	1,068 $666,000
Q1 2020 Apr 17, 2020	BUY	$336.18 - $494.43 $169,770 - $249,687	505 New	505 $247,000

Others Institutions Holding REGN

# of Institutions

1,427

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $110B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Account

Wedbush Securities Inc Regeneron Pharmaceuticals, Inc. Transaction History